The clinical trial will evaluate the PerQdisc device for patients suffering from degenerative disc disease, according to a March 4 news release. The system is an alternative to spinal fusion and disc replacement.
Spinal Stabilization Technologies said it raised $17 million from new and existing investors to support the trial and advance other clinical initiatives.
Additionally, the company added Frank Phillips, MD, to its Board of Directors. Dr. Phillips is a renowned spine surgeon with several patents and more than 200 publications. He has also pioneered minimally invasive procedures and launched several spine companies.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
